UVFT (UV Flu Technologies) Debt-to-Equity: -0.43 (As of Mar. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is UV Flu Technologies Debt-to-Equity?

UV Flu Technologies UVFT Debt-to-Equity is -0.43 as of Mar. 2016.

UV Flu Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2016 was $0.23 Mil. UV Flu Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2016 was $0.01 Mil. UV Flu Technologies's Total Stockholders Equity for the quarter that ended in Mar. 2016 was $-0.57 Mil. UV Flu Technologies's debt to equity for the quarter that ended in Mar. 2016 was -0.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for UV Flu Technologies's Debt-to-Equity or its related term are showing as below:

UVFT's Debt-to-Equity is not ranked *
in the Industrial Products industry.
Industry Median: 0.29
* Ranked among companies with meaningful Debt-to-Equity only.

UV Flu Technologies  (OTCPK:UVFT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

UV Flu Technologies Debt-to-Equity Related Terms

UV Flu Technologies Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for UV Flu Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UV Flu Technologies Debt-to-Equity Chart

UV Flu Technologies Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only -3.04 0.58 -9.48 -0.46 -0.46

UV Flu Technologies Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.69 -0.57 -0.46 -0.53 -0.43

UVFT vs PCTL, DSOX, CDTI: Debt-to-Equity Comparison

For the Pollution & Treatment Controls subindustry, UV Flu Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

UV Flu Technologies Debt-to-Equity vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, UV Flu Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where UV Flu Technologies's Debt-to-Equity falls into.


UV Flu Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

UV Flu Technologies's Debt to Equity Ratio for the fiscal year that ended in Sep. 2015 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.315 + 0) / -0.683
=-0.46

UV Flu Technologies's Debt to Equity Ratio for the quarter that ended in Mar. 2016 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.233 + 0.014) / -0.571
=-0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of -0.43 mean?
UV Flu Technologies (UVFT) has a Debt-to-Equity of -0.43 as of Mar. 2016. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on UV Flu Technologies and its competitors.
Is UV Flu Technologies' Debt-to-Equity too high?
UV Flu Technologies' current Debt-to-Equity is -0.43.
How does UV Flu Technologies' Debt-to-Equity compare to PCTL and DSOX?
UV Flu Technologies' Debt-to-Equity of -0.43 can be compared against companies in the Industrial Products industry. The industry median Debt-to-Equity is 0.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Industrial Products company?
The median Debt-to-Equity among Industrial Products companies is 0.29, based on 2,690 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on UV Flu Technologies and its competitors. For the Industrial Products industry, the median Debt-to-Equity is 0.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UV Flu Technologies's current Debt-to-Equity is -0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UV Flu Technologies stock overvalued right now?
UV Flu Technologies (UVFT) has a current Debt-to-Equity of -0.43. The current Debt-to-Equity is -0.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For UV Flu Technologies (UVFT), the current Debt-to-Equity is -0.43 as of Mar. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

UV Flu Technologies Business Description

Address 250 Parkway Drive, Suite 150, Lincolnshire, IL, USA, 60069
UV Flu Technologies Inc is a manufacturer of the finest air purification systems. In addition, it also acts as a developer, manufacturer, and distributor of biotechnology products targeting the rapidly growing Indoor Air Quality industry sector. The company's flagship product is the ViraTech-RX-400 model which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to destroy harmful bacteria. All of UV Flu's products are manufactured in the United States of America.